SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: yosi s who wrote (965)1/21/2000 4:59:00 PM
From: arnie h  Read Replies (1) of 1386
 
Yosi: I'd remind the thread we were told in the Annual meeting that the results from the 2nd cohort would be unblinded in the middle of January. As we are now just past the middle of January, one would presume the trial has been unblinded. There are a number of possibilities for the stock price movement as a result. The most favorable is that some have been able to read the 'body language' and decided results are positive. Since prior results were not strong enough to interest other primary players in an arrangement of sufficient interest, perhaps the guess is that the new results will do the trick. Another possibility, of course, is that some have read the tea leaves and decided to pump the price through rumor so they can bow out gracefully. In the light of the good price movement, and today's close above a resistance point from a technical perspective, the former seems more consistent. We'll know in a bit after the results are digested and interpreted.
Regards,
Arnie
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News